Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA)

By Choi Moon  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1234-1238

Humana Press, Inc

Access to resources Recommend Favorite

Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma

By Ren Pengfei   Ye Hua   Dai Liping   Liu Mei   Liu Xinxin   Chai Yurong   Shao Qing   Li Yang   Lei Ningjing   Peng Bo   Yao Wu   Zhang Jianying  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2297-2303

Spandidos Publications

Access to resources Recommend Favorite

The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma

By                          

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1353-1360

Spandidos Publications

Access to resources Recommend Favorite

Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck?

By Jatana Kris R   Lang Jas C   Chalmers Jeffrey J  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 481-484

Future Medicine

Access to resources Recommend Favorite

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

By                      

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 465-472

Spandidos Publications

Access to resources Recommend Favorite